The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Glycobiology

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/glycob/cwx022PMID 28334832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

  2018cited by this paper
• ggplot2 - Elegant Graphics for Data Analysis (2nd Edition)

  2017cited by this paper
• Profiling IgG N-glycans as potential biomarker of chronological and biological ages

  2016cited by this paper
• IgG Glycome in Colorectal Cancer

  2016cited by this paper
• Sweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation

  2016cited by this paper
• The Association Between Glycosylation of Immunoglobulin G and Hypertension

  2016cited by this paper
• Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

  2015cited by this paper
• Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome

  2015cited by this paper
• IgG Subclasses and Allotypes: From Structure to Effector Functions

  2014cited by this paper
• Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease

  2014cited by this paper
• Systemic inflammation regulates microglial responses to tissue damage in vivo

  2014influential reference
• Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health

  2014cited by this paper
• The impact of dementia development concurrent with Parkinson's disease: a new perspective.

  2014cited by this paper
• Initial cognitive decline is associated with cortical thinning in early Parkinson disease

  2014influential reference
• Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• The association between galactosylation of immunoglobulin G and body mass index.

  2014cited by this paper
• Parkinson disease subtypes.

  2014cited by this paper
• Predictors of cognitive impairment in an early stage Parkinson’s disease cohort

  2014influential reference
• N-glycomic biomarkers of biological aging and longevity: a link with inflammaging.

  2013cited by this paper
• Measuring mild cognitive impairment in patients with Parkinson's disease

  2013cited by this paper
• Glycans Are a Novel Biomarker of Chronological and Biological Ages

  2013influential reference
• Antibody Glycosylation and Inflammation

  2013cited by this paper
• Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers

  2013influential reference
• How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

  2013cited by this paper
• The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

  2013influential reference
• Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

  2013influential reference
• Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?

  2013cited by this paper
• Blood Plasma IgG Fc Glycans are Significantly Altered in Alzheimer's Disease and Progressive Mild Cognitive Impairment

  2013influential reference
• Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.

  2013influential reference
• The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis.

  2013cited by this paper
• Transmission of alpha-synuclein in Parkinson’s disease

  2013cited by this paper
• β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia

  2013cited by this paper
• Glycosylation of Immunoglobulin G: Role of Genetic and Epigenetic Influences

  2013cited by this paper
• Change in IgG1 Fc N‐linked glycosylation in human lung cancer: Age‐ and sex‐related diagnostic potential

  2013cited by this paper
• Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice

  2013cited by this paper
• Strategies for the profiling, characterisation and detailed structural analysis of N-linked oligosaccharides

  2013cited by this paper
• Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.

  2013cited by this paper
• Neuropathologic substrates of Parkinson disease dementia

  2012cited by this paper
• The role of sialic acid as a modulator of the anti-inflammatory activity of IgG

  2012cited by this paper
• A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.

  2012influential reference
• Recent progress in quantitative glycoproteomics

  2012influential reference
• Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

  2012influential reference
• Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer.

  2012cited by this paper
• Harnessing glycomics technologies: Integrating structure with function for glycan characterization

  2012influential reference
• IgG Glycosylation Changes and MBL2 Polymorphisms: Associations with Markers of Systemic Inflammation and Joint Destruction in Rheumatoid Arthritis

  2012cited by this paper
• Novel roles for the IgG Fc glycan

  2012cited by this paper
• The fine specificity of mannose-binding and galactose-binding lectins revealed using outlier motif analysis of glycan array data.

  2012influential reference
• The enteric nervous system and neurogastroenterology

  2012influential reference
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.

  2012influential reference
• Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?

  2012cited by this paper
• Association of medication with the human plasma N-glycome.

  2012cited by this paper
• Suboptimal health: a potential preventive instrument for non-communicable disease control and management: Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations

  2012influential reference
• Calculating a robust correlation coefficient and quantifying its uncertainty

  2012cited by this paper
• Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

  2012influential reference
• Lewy pathology and neurodegeneration in premotor Parkinson's disease

  2012influential reference
• Prevalence of Parkinson disease and Parkinson disease dementia in community nursing homes.

  2012influential reference
• Parkinson Disease: The Enteric Nervous System Spills its Guts

  2012influential reference
• Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo

  2012cited by this paper
• Parkinson Subtypes Progress Differently in Clinical Course and Imaging Pattern

  2012influential reference
• Parkinson disease

  2011cited by this paper
• Mitochondrial Dysfunction in Parkinson's Disease

  2011cited by this paper
• Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival

  2011cited by this paper
• Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

  2011cited by this paper
• Physiology of microglia.

  2011cited by this paper
• Rotenone, Paraquat, and Parkinson’s Disease

  2011influential reference
• Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease.

  2011cited by this paper
• Priorities in Parkinson's disease research

  2011influential reference
• Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database

  2011cited by this paper
• Evolutional and clinical implications of the epigenetic regulation of protein glycosylation

  2011influential reference
• Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

  2011cited by this paper
• Fc-Glycosylation of IgG1 is Modulated by B-cell Stimuli*

  2011cited by this paper
• Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.

  2011cited by this paper
• Functional analysis of agalactosyl IgG in inflammatory bowel disease patients

  2011cited by this paper
• The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo

  2011influential reference
• Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose

  2011cited by this paper
• Dementia in Parkinson's disease: a Brazilian sample.

  2011influential reference
• Coping processes and health‐related quality of life in Parkinson's disease

  2011cited by this paper
• High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

  2011influential reference
• Exercise and Parkinson’s: benefits for cognition and quality of life

  2011cited by this paper
• Akinetic‐rigid and tremor‐dominant Parkinson's disease patients show different patterns of FP‐CIT Single photon emission computed tomography

  2011influential reference
• Mild Cognitive Impairment in Parkinson’s Disease

  2011cited by this paper
• Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease

  2010cited by this paper
• Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice

  2010cited by this paper
• Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity

  2010cited by this paper
• Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans.

  2010influential reference
• An R Companion to Applied Regression

  2010cited by this paper
• Protein glycosylation--an evolutionary crossroad between genes and environment.

  2010influential reference
• Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.

  2010influential reference
• Biomarkers for Cognitive Impairment in Parkinson Disease

  2010cited by this paper
• Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms

  2010cited by this paper
• Altered Serum Glycomics in Alzheimer Disease: A Potential Blood Biomarker?

  2010cited by this paper
• Microglia in neurodegenerative disease

  2010influential reference
• Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

  2010cited by this paper
• The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease.

  2010cited by this paper
• Mitochondrial dysfunction in Parkinson's disease.

  2010cited by this paper
• α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

  2010cited by this paper
• Tackling the widespread and critical impact of batch effects in high-throughput data

  2010influential reference
• Common aberrations from the normal human plasma N-glycan profile.

  2010influential reference
• Parkinson's disease: from monogenic forms to genetic susceptibility factors.

  2009cited by this paper

• Sialylation in the Nervous System: Functions and Mechanisms.

  2026cites this paper
• Advances in MS-based glycomics for biomedical research.

  2025cites this paper
• Immunoglobulin G N-glycosylation predicts long-term risk of ischemic stroke: a nested case-control study

  2025cites this paper
• Altered Cell Surface N-Glycosylation Implicates Hypersialylation in Breast Cancer Brain Metastasis.

  2025cites this paper
• Association between immunoglobulin G N-glycosylation, inflammatory factors, and ankylosing spondylitis: A case–control study

  2025cites this paper
• Deep Reinforcement Learning–Driven Multi-Omics Integration for Constructing gtAge: A Novel Aging Clock from IgG N-glycome and Blood Transcriptome

  2025cites this paper
• Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine

  2025cites this paper
• The Association Between Neonatal Respiratory Distress Syndrome and Plasma IgG N-Glycosylation: A Case-Control Study

  2025cites this paper
• Fast NMR-Based Assessment of Cancer-Associated Protein Glycosylations from Serum Samples

  2025cites this paper
• Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling

  2025cites this paper
• Immunoglobulin G N-Glycosylation and Inflammatory Factors: Analysis of Biomarkers for the Diagnosis of Moyamoya Disease

  2025cites this paper
• Influence of plasma collection tubes on N-glycome in human blood samples

  2024cites this paper
• Differences in IgG afucosylation between groups with and without carotid atherosclerosis

  2024cites this paper
• Glycosylation in aging and neurodegenerative diseases

  2024cites this paper
• Neuroglycome alterations of hippocampus and prefrontal cortex of juvenile rats chronically exposed to glyphosate-based herbicide

  2024cites this paper
• The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes

  2024cites this paper
• Clinical glycoprotein mass spectrometry: The future of disease detection and monitoring.

  2024cites this paper
• Immunoglobulin G glycosylation and its alterations in aging-related diseases

  2024cites this paper
• Serum N-Glycan Profiling of Patients with Narcolepsy Type 1 Using LC-MS/MS

  2024cites this paper
• Recent advances in N-glycan biomarker discovery among human diseases

  2024cites this paper
• The association between plasma IgG N-glycosylation and neonatal hypoxic–ischemic encephalopathy: a case-control study

  2024cites this paper
• High-Throughput Glycan Profiling of Human Serum IgG Subclasses Using Parallel Reaction Monitoring Peptide Bond Fragmentation of Glycopeptides and Microflow LC-MS.

  2024cites this paper
• High-Throughput Profiling of Serological Immunoglobulin G N-Glycome as a Noninvasive Biomarker of Gastrointestinal Cancers

  2023cites this paper
• An integrated method for IgG N-glycans enrichment and analysis: Understanding the role of IgG glycosylation in diabetic foot ulcer.

  2023cites this paper
• Advances in neuroproteomics for neurotrauma: unraveling insights for personalized medicine and future prospects

  2023cites this paper
• Development of an impedance-based biosensor for determination of IgG galactosylation levels.

  2023cites this paper
• Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study

  2023cites this paper
• Mass Spectrometric Analysis of Urinary N-Glycosylation Changes in Patients with Parkinson's Disease.

  2023cites this paper
• Genetic control of N-glycosylation of human blood plasma proteins

  2023cites this paper
• IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy.

  2023cites this paper
• Storage stability and HILIC-UHPLC-FLR analysis of immunoglobulin G N-glycome from saliva

  2023cites this paper
• Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma

  2023cites this paper
• IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers

  2023cites this paper
• Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases

  2023cites this paper
• IgG N-Glycosylation Cardiovascular Age Tracks Cardiovascular Risk Beyond Calendar Age

  2023cites this paper
• A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer’s and Parkinson’s Disease

  2023cites this paper
• Changes in tissue protein N-glycosylation and associated molecular signature occur in the human Parkinsonian brain in a region-specific manner

  2023influential citation
• MS-based glycomics: An analytical tool to assess nervous system diseases

  2022cites this paper
• Immunoglobulin G N-glycan, inflammation and type 2 diabetes in East Asian and European populations: a Mendelian randomization study

  2022cites this paper
• Immunoglobulin G glycans - biomarkers and molecular effectors of aging.

  2022cites this paper
• Identification of Mobility-Resolved N-Glycan Isomers

  2022cites this paper
• Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson’s disease

  2022cites this paper
• Mass Spectrometry-Based Analysis of Serum N-Glycosylation Changes in Patients with Parkinson's Disease.

  2022cites this paper
• Role and therapeutic implications of protein glycosylation in neuroinflammation.

  2022cites this paper
• Tourism as a dementia treatment based on positive psychology

  2022cites this paper
• Application progress of magnetic molecularly imprinted polymers chemical sensors in the detection of biomarkers.

  2022cites this paper
• Genetic regulation of post-translational modification of two distinct proteins

  2022cites this paper
• Small molecule inhibitors of mammalian glycosylation

  2022cites this paper
• Association Between Immunoglobulin G N-glycosylation and Vascular Cognitive Impairment in a Sample With Atherosclerosis: A Case-Control Study

  2022cites this paper
• The role of IgG N-galactosylation in Spondyloarthritis

  2022cites this paper
• Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder

  2022influential citation
• Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis

  2021cites this paper
• The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers

  2021cites this paper
• Preparation of IgG imprinted polymers by metal-free visible-light-induced ATRP and its application in biosensor

  2021cites this paper
• Association of dementia with immunoglobulin G N-glycans in a Chinese Han Population

  2021cites this paper
• Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach

  2021cites this paper
• Multivariate genome-wide analysis of immunoglobulin G N-glycosylation identifies new loci pleiotropic with immune function.

  2021cites this paper
• Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases

  2021cites this paper
• A Rapidly Aging World in the 21st Century: Hopes from Glycomics and Unraveling the Biomarkers of Aging with the Sugar Code

  2021cites this paper
• N-glycosylation profiling of Type 2 diabetes mellitus from baseline to follow-up: an observational study in a Ghanaian population.

  2021cites this paper
• IgG N-glycans.

  2021cites this paper
• Genetic regulation of post-translational modification of two distinct proteins

  2021cites this paper
• Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.

  2021cites this paper
• The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson’s Disease

  2021cites this paper
• Screening and diagnosis of colorectal cancer and advanced adenoma by Bionic Glycome method and machine learning.

  2021cites this paper
• Quantitative Genetics of Human Protein N-Glycosylation.

  2021cites this paper
• Glycosylation Profiling as a Biomarker of Suboptimal Health Status for Chronic Disease Stratification.

  2021cites this paper
• Advances in mass spectrometry‐based glycomics—An update covering the period 2017–2021

  2021cites this paper
• Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study

  2021cites this paper
• LC-MS/MS in glycomics and glycoproteomics analyses

  2021cites this paper
• Immunoglobulin G Glycosylation in Diseases.

  2021cites this paper
• The Rapidly Expanding Nexus of Immunoglobulin G N-Glycomics, Suboptimal Health Status, and Precision Medicine.

  2021cites this paper
• Capillary (Gel) Electrophoresis-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

  2021cites this paper
• Genetic Regulation of Immunoglobulin G Glycosylation.

  2021cites this paper
• Heritability Enrichment of Immunoglobulin G N-Glycosylation in Specific Tissues

  2021cites this paper
• Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease

  2021cites this paper
• Investigation of the causal relationships between human IgG N-glycosylation and twelve common diseases associated with changes in the IgG N-glycome.

  2021cites this paper
• Association of dementia with immunoglobulin G N-glycans in a Chinese Han Population

  2021cites this paper
• A clinically viable assay for monitoring uromodulin glycosylation

  2021cites this paper
• Replication of fifteen loci involved in human plasma protein N-glycosylation in 4 , 802 samples from four cohorts Word count : 3952 words Key words : genetic association study / glycosylation / locus / total plasma N-glycome / replication

  2020cites this paper
• Genome plasticity and endocrine diseases

  2020cites this paper
• Simple and Complex Sugars in Parkinson’s Disease: a Bittersweet Taste

  2020cites this paper
• A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus

  2020cites this paper
• Replication of fifteen loci involved in human plasma protein N-glycosylation in 4,802 samples from four cohorts.

  2020cites this paper
• Serum immunoglobulin G N-glycome: a potential biomarker in endometrial cancer

  2020cites this paper
• The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease

  2020cites this paper
• Glycomics: Immunoglobulin G N-Glycosylation Associated with Mammary Gland Hyperplasia in Women

  2020influential citation
• Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis

  2020cites this paper
• Altered N-glycan profile of IgG-depleted serum proteins in Hashimoto's thyroiditis.

  2020cites this paper
• Knowledge Domain and Emerging Trends of IgG Glycosylation: A Bibliometric Study Based on CiteSpace

  2020cites this paper
• So You Discovered a Potential Glycan-Based Biomarker; Now What? We Developed a High-Throughput Method for Quantitative Clinical Glycan Biomarker Validation

  2020cites this paper
• A large-scale genetic correlation scan identified the plasma proteins associated with brain function related traits.

  2020cites this paper
• Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling

  2020cites this paper
• Clinically Viable Assay for Monitoring Uromodulin Glycosylation.

  2020cites this paper
• Glycomics Research in China: The Current State of the Art

  2019cites this paper
• Peripheral Humoral Immune Response Is Associated With the Non-motor Symptoms of Parkinson’s Disease

  2019cites this paper
• Utilization of N-glycosylation profiles as risk stratification biomarkers for suboptimal health status and metabolic syndrome in a Ghanaian population.

  2019cites this paper
• Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting.

  2019cites this paper
• Revealing the Biological Attributes of N-Glycan Isomers in Breast Cancer Brain Metastasis Using Porous Graphitic Carbon (PGC) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

  2019cites this paper
• Systematic Review: Immunoglobulin G N-Glycans as Next-Generation Diagnostic Biomarkers for Common Chronic Diseases.

  2019cites this paper